Medical Weight Loss for Wilmington, Delaware Residents
Wilmington, Delaware residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.
Physician-supervised GLP-1 programs from $166/month · just $5.50/day, serving Wilmington through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.
Why Wilmington Residents Choose New Hope Weight Loss
Since 2020, New Hope Weight Loss has treated more than 5,400 patients from its Costa Mesa, California clinic, and Wilmington, Delaware residents get that same physician-led program by telehealth. Pricing is flat and transparent, with care overseen by Dr. Anjmun Sharma, M.D., and no insurance required to start.
Wilmington is served through telehealth from our Costa Mesa, California clinic. The full physician-supervised GLP-1 program runs by secure video, with compounded medication shipped to your Wilmington address.
Although our clinic is physically in Costa Mesa, California, Wilmington residents receive the same physician-supervised care without leaving Delaware. We care for patients throughout Downtown, Trolley Square, Riverside, the Highlands, and New Castle County. Every prescription for Wilmington is authorized by Dr. Sharma after reviewing your history, and follow-up continues by video throughout the program.
Like much of Delaware, many people in Wilmington want a physician-supervised weight-loss option without local waitlists or unclear pricing. Compounded medication arrives in discreet, cold-pack packaging at your Wilmington address, usually within days.
GLP-1 Weight Loss Programs Available
Two GLP-1 programs for Wilmington
Compounded semaglutide starts at $166/month (a 90-day program is $499) and uses the same active ingredient as Wegovy® and Ozempic®, which produced 15-17% average body-weight loss in clinical trials. Compounded tirzepatide starts at $233/month · just $7.70/day and uses a dual GLP-1/GIP mechanism shown to reach up to 22.5% in trials.
Every plan begins with a $119 physician review. Medication is billed separately, and HSA, FSA, Klarna, and Affirm are all accepted, with no distance surcharge.
How Telehealth Works for Wilmington
1. Tell us your history through the quiz or intake form. 2. Dr. Sharma confirms your eligibility by secure video, usually within 48 hours. 3. Your compounded medication arrives at your Wilmington address in cold-pack packaging, with ongoing follow-up from the team, all without leaving home.
Frequently Asked Questions, Wilmington
Does New Hope Weight Loss treat patients in Wilmington?
Yes. Although the clinic is in Costa Mesa, California, we treat Wilmington, Delaware residents by telehealth, Dr. Sharma reviews your case by secure video and compounded medication ships to your home. Eligibility is confirmed during the consultation.
Do I have to travel to get started from Wilmington?
No travel is needed. The whole process, intake, consultation, and follow-ups, is by secure video, and your medication arrives at your Wilmington address in cold-pack packaging.
What do Wilmington patients pay?
Flat nationwide pricing: $119 for the physician review, then semaglutide from $166/month and tirzepatide from $233/month, medication billed separately. HSA, FSA, Klarna, and Affirm are accepted, with no distance surcharge.
What areas of Wilmington do you serve?
We serve patients from across Wilmington by telehealth, including Downtown, Trolley Square, Riverside, the Highlands, and New Castle County.
Is telehealth treatment as thorough as an in-person visit for Wilmington patients?
Yes. Wilmington patients get the same physician review by Dr. Sharma, the same contraindication screening, the same dose titration, and the same health-advisor support as any patient. Everything except a physical exam is handled by secure video, and compounded medication ships to your door. Telehealth eligibility is confirmed during the consultation.
New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Wilmington, Delaware by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.